Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1997 Mar;90(3):358–363. doi: 10.1111/j.1365-2567.1997.00358.x

Tumour necrosis factor-alpha up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells.

A Andoh 1, Y Fujiyama 1, K Sumiyoshi 1, H Sakumoto 1, H Okabe 1, T Bamba 1
PMCID: PMC1456598  PMID: 9155641

Abstract

The increased expression of decay-accelerating factor (DAF) has been detected in intestinal epithelial cells at the inflamed mucosa. In this study, we examined the effects of tumour necrosis factor (TNF)-alpha on DAF expression in three intestinal epithelial cell lines. DAF mRNA expression was evaluated by Northern blot analysis, and DAF protein expression was analysed by biotin labelling and immunoprecipitation. TNF-alpha induced a marked increase in DAF mRNA and protein expression in HT-29, T84 and Caco-2 cells. In HT-29 cells, the effects of TNF-a on DAF mRNA accumulation were observed in a dose-dependent manner; DAF mRNA accumulation reached a maximum at 3-6 hr, and then gradually decreased. These effects of TNF-alpha required de novo protein synthesis. Messenger RNA stability studies suggested that TNF-alpha partially regulated DAF gene expression by a posttranscriptional mechanism. Moreover, the combination of TNF-alpha and interleukin (IL)-4 induced an additive increase in DAF mRNA accumulation in HT-29 and T84 cells. In human intestinal epithelial cells, TNF-alpha acts as a potent inducer of DAF mRNA expression, indicating an important role for TNF-alpha in the regulation of DAF expression at the inflamed mucosa.

Full text

PDF
358

Images in this article

359Figure 1
on p.359
360Figure 2
on p.360
360Figure 3
on p.360
360Figure 4
on p.360
361Figure 6
on p.361
361Figure 7
on p.361
361Figure 8
on p.361

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abreu-Martin M. T., Vidrich A., Lynch D. H., Targan S. R. Divergent induction of apoptosis and IL-8 secretion in HT-29 cells in response to TNF-alpha and ligation of Fas antigen. J Immunol. 1995 Nov 1;155(9):4147–4154. [PubMed] [Google Scholar]
  2. Ahrenstedt O., Knutson L., Nilsson B., Nilsson-Ekdahl K., Odlind B., Hällgren R. Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med. 1990 May 10;322(19):1345–1349. doi: 10.1056/NEJM199005103221903. [DOI] [PubMed] [Google Scholar]
  3. Andoh A., Fujiyama Y., Bamba T., Hosoda S. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol. 1993 Oct 15;151(8):4239–4247. [PubMed] [Google Scholar]
  4. Andoh A., Fujiyama Y., Sumiyoshi K., Bamba T. Local secretion of complement C3 in the exocrine pancreas: ductal epithelial cells as a possible biosynthetic site. Gastroenterology. 1996 Jun;110(6):1919–1925. doi: 10.1053/gast.1996.v110.pm8964419. [DOI] [PubMed] [Google Scholar]
  5. Andoh A., Fujiyama Y., Sumiyoshi K., Sakumoto H., Bamba T. Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells. Gastroenterology. 1996 Oct;111(4):911–918. doi: 10.1016/s0016-5085(96)70058-6. [DOI] [PubMed] [Google Scholar]
  6. Braegger C. P., Nicholls S., Murch S. H., Stephens S., MacDonald T. T. Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet. 1992 Jan 11;339(8785):89–91. doi: 10.1016/0140-6736(92)90999-j. [DOI] [PubMed] [Google Scholar]
  7. Breese E. J., Michie C. A., Nicholls S. W., Murch S. H., Williams C. B., Domizio P., Walker-Smith J. A., MacDonald T. T. Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology. 1994 Jun;106(6):1455–1466. doi: 10.1016/0016-5085(94)90398-0. [DOI] [PubMed] [Google Scholar]
  8. Bryant R. W., Granzow C. A., Siegel M. I., Egan R. W., Billah M. M. Phorbol esters increase synthesis of decay-accelerating factor, a phosphatidylinositol-anchored surface protein, in human endothelial cells. J Immunol. 1990 Jan 15;144(2):593–598. [PubMed] [Google Scholar]
  9. Bryant R. W., Granzow C. A., Siegel M. I., Egan R. W., Billah M. M. Wheat germ agglutinin and other selected lectins increase synthesis of decay-accelerating factor in human endothelial cells. J Immunol. 1991 Sep 15;147(6):1856–1862. [PubMed] [Google Scholar]
  10. Caras I. W., Davitz M. A., Rhee L., Weddell G., Martin D. W., Jr, Nussenzweig V. Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature. 1987 Feb 5;325(6104):545–549. doi: 10.1038/325545a0. [DOI] [PubMed] [Google Scholar]
  11. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  12. Dealtry G. B., Naylor M. S., Fiers W., Balkwill F. R. The effect of recombinant human tumour necrosis factor on growth and macromolecular synthesis of human epithelial cells. Exp Cell Res. 1987 Jun;170(2):428–438. doi: 10.1016/0014-4827(87)90318-1. [DOI] [PubMed] [Google Scholar]
  13. Dharmsathaphorn K., McRoberts J. A., Mandel K. G., Tisdale L. D., Masui H. A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol. 1984 Feb;246(2 Pt 1):G204–G208. doi: 10.1152/ajpgi.1984.246.2.G204. [DOI] [PubMed] [Google Scholar]
  14. Hekmati M., Polak-Charcon S., Ben-Shaul Y. A morphological study of a human adenocarcinoma cell line (HT29) differentiating in culture. Similarities to intestinal embryonic development. Cell Differ Dev. 1990 Sep;31(3):207–218. doi: 10.1016/0922-3371(90)90133-h. [DOI] [PubMed] [Google Scholar]
  15. Holmes C. H., Simpson K. L., Wainwright S. D., Tate C. G., Houlihan J. M., Sawyer I. H., Rogers I. P., Spring F. A., Anstee D. J., Tanner M. J. Preferential expression of the complement regulatory protein decay accelerating factor at the fetomaternal interface during human pregnancy. J Immunol. 1990 Apr 15;144(8):3099–3105. [PubMed] [Google Scholar]
  16. Inoue H., Mizuno M., Uesu T., Ueki T., Tsuji T. Distribution of complement regulatory proteins, decay-accelerating factor, CD59/homologous restriction factor 20 and membrane cofactor protein in human colorectal adenoma and cancer. Acta Med Okayama. 1994 Oct;48(5):271–277. doi: 10.18926/AMO/31112. [DOI] [PubMed] [Google Scholar]
  17. Kinoshita T., Medof M. E., Silber R., Nussenzweig V. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med. 1985 Jul 1;162(1):75–92. doi: 10.1084/jem.162.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kooyman D. L., Byrne G. W., McClellan S., Nielsen D., Tone M., Waldmann H., Coffman T. M., McCurry K. R., Platt J. L., Logan J. S. In vivo transfer of GPI-linked complement restriction factors from erythrocytes to the endothelium. Science. 1995 Jul 7;269(5220):89–92. doi: 10.1126/science.7541557. [DOI] [PubMed] [Google Scholar]
  19. Koretz K., Brüderlein S., Henne C., Möller P. Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br J Cancer. 1992 Nov;66(5):810–814. doi: 10.1038/bjc.1992.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Le Bivic A., Quaroni A., Nichols B., Rodriguez-Boulan E. Biogenetic pathways of plasma membrane proteins in Caco-2, a human intestinal epithelial cell line. J Cell Biol. 1990 Oct;111(4):1351–1361. doi: 10.1083/jcb.111.4.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Medof M. E., Walter E. I., Rutgers J. L., Knowles D. M., Nussenzweig V. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J Exp Med. 1987 Mar 1;165(3):848–864. doi: 10.1084/jem.165.3.848. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Morgan B. P. Complement regulatory molecules: application to therapy and transplantation. Immunol Today. 1995 Jun;16(6):257–259. doi: 10.1016/0167-5699(95)80175-8. [DOI] [PubMed] [Google Scholar]
  23. Mullin J. M., Snock K. V. Effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res. 1990 Apr 1;50(7):2172–2176. [PubMed] [Google Scholar]
  24. Murch S. H., Lamkin V. A., Savage M. O., Walker-Smith J. A., MacDonald T. T. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991 Aug;32(8):913–917. doi: 10.1136/gut.32.8.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ohshio G., Furukawa F., Manabe T., Tobe T., Hamashima Y. Comparative studies on immunoglobulins, complement component (C3), albumin, and immunoglobulin A-containing circulating immune complexes in serum and bile of patients with biliary obstruction. Dig Dis Sci. 1988 May;33(5):570–576. doi: 10.1007/BF01798359. [DOI] [PubMed] [Google Scholar]
  26. Post T. W., Arce M. A., Liszewski M. K., Thompson E. S., Atkinson J. P., Lublin D. M. Structure of the gene for human complement protein decay accelerating factor. J Immunol. 1990 Jan 15;144(2):740–744. [PubMed] [Google Scholar]
  27. Riesbeck K., Sigvardsson M., Leanderson T., Forsgren A. Superinduction of cytokine gene transcription by ciprofloxacin. J Immunol. 1994 Jul 1;153(1):343–352. [PubMed] [Google Scholar]
  28. Shaw G., Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 1986 Aug 29;46(5):659–667. doi: 10.1016/0092-8674(86)90341-7. [DOI] [PubMed] [Google Scholar]
  29. Uesu T., Mizuno M., Inoue H., Tomoda J., Tsuji T. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis. Lab Invest. 1995 May;72(5):587–591. [PubMed] [Google Scholar]
  30. Vassalli P. The pathophysiology of tumor necrosis factors. Annu Rev Immunol. 1992;10:411–452. doi: 10.1146/annurev.iy.10.040192.002211. [DOI] [PubMed] [Google Scholar]
  31. Zubiaga A. M., Muñoz E., Huber B. T. Superinduction of IL-2 gene transcription in the presence of cycloheximide. J Immunol. 1991 Jun 1;146(11):3857–3863. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES